BioXcel Therapeutics, Inc.
Biotechnology ResearchConnecticut, United States51-200 Employees
Biopharmaceutical company developing transformative medicines in neuroscience utilizing artificial intelligence
Insights
AI-driven Drug Development BioXcel Therapeutics leverages artificial intelligence in developing transformative medicines in neuroscience, presenting a unique selling point to potential partners or investors interested in cutting-edge technology-driven solutions.
Patent Acquisition for Expansion Recent investments in acquiring two new patents reflect BioXcel Therapeutics' commitment to innovation and expansion, offering a strategic advantage that can attract collaborations or licensing deals.
Phase 3 Trial Plans The company's ongoing Phase 3 trials like SERENITY At-Home and TRANQUILITY In-Care present opportunities for partnerships with healthcare providers, clinical research organizations, or pharmaceutical distributors seeking to align with breakthrough therapies.
Specialty Pharmacy Network Collaboration Partnering with specialty pharmacy services like Polaris Specialty Pharmacy indicates BioXcel Therapeutics' focus on market access and patient support, making it appealing for pharmacy chains or healthcare networks looking to enhance their service offerings.
Strategic Financing Moves Securing significant financing of $25 million demonstrates financial stability and growth potential, making BioXcel Therapeutics an attractive collaboration prospect for investment firms, venture capitalists, or entities looking for high-growth biotech opportunities.
Similar companies to BioXcel Therapeutics, Inc.
Adaptimmune
537
$50M$100MPliant Therapeutics
184$10M$50MArvinas
447$50M$100MKodiak Sciences
104$10M$50MAlkermes
2.2K$1BAllogene Therapeutics
282$50M$100MLogicBio Therapeutics
51$10M$50Mbluebird bio
587$50M$100MTwist Bioscience
1.1K$100M$1BTurning Point Therapeutics
201$50M$100M
BioXcel Therapeutics, Inc. Tech Stack
BioXcel Therapeutics, Inc. uses 8 technology products and services including Microsoft Word, Swiper, scikit-learn, and more. Explore BioXcel Therapeutics, Inc.'s tech stack below.
- Microsoft WordEditors
- SwiperJavascript Libraries
- scikit-learnMachine Learning
- Windows ServerOperating Systems
- Amazon Web ServicesPlatform As A Service
- LinuxProgramming Languages
- reCAPTCHASecurity
- HSTSSecurity
Media & News
BioXcel Therapeutics, Inc.'s Email Address Formats
BioXcel Therapeutics, Inc. uses at least 1 format(s):
| BioXcel Therapeutics, Inc. Email Formats | Percentage |
| FLast@bioxceltherapeutics.com | 97% |
| First@bioxceltherapeutics.com | 1% |
| FMiddleLast@bioxceltherapeutics.com | 1% |
| FirstLast@bioxceltherapeutics.com | 1% |
Frequently Asked Questions
Where is BioXcel Therapeutics, Inc.'s headquarters located?
BioXcel Therapeutics, Inc.'s main headquarters is located at 555 Long Wharf Dr 12th floor New Haven, Connecticut 06511 US. The company has employees across 3 continents, including North AmericaAsiaEurope. What is BioXcel Therapeutics, Inc.'s phone number?
You can contact BioXcel Therapeutics, Inc.'s main corporate office by phone at +1-203-643-****
What is BioXcel Therapeutics, Inc.'s stock symbol?
BioXcel Therapeutics, Inc. is a publicly traded company; the company's stock symbol is BTAI. What is BioXcel Therapeutics, Inc.'s official website and social media links?
BioXcel Therapeutics, Inc.'s official website is bioxceltherapeutics.com and has social profiles on LinkedIn.How much revenue does BioXcel Therapeutics, Inc. generate?
As of November 2024, BioXcel Therapeutics, Inc.'s annual revenue reached $35M. What is BioXcel Therapeutics, Inc.'s SIC code NAICS code?
BioXcel Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does BioXcel Therapeutics, Inc. have currently?
As of November 2024, BioXcel Therapeutics, Inc. has approximately 89 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer: V. M.Chief Medical Officer, Neuroscience: R. R.Chief Medical Officer: V. J.. Explore BioXcel Therapeutics, Inc.'s employee directory with LeadIQ.What industry does BioXcel Therapeutics, Inc. belong to?
BioXcel Therapeutics, Inc. operates in the Biotechnology Research industry. What technology does BioXcel Therapeutics, Inc. use?
BioXcel Therapeutics, Inc.'s tech stack includes Microsoft WordSwiperscikit-learnWindows ServerAmazon Web ServicesLinuxreCAPTCHAHSTS. What is BioXcel Therapeutics, Inc.'s email format?
BioXcel Therapeutics, Inc.'s email format typically follows the pattern of . Find more BioXcel Therapeutics, Inc. email formats with LeadIQ. When was BioXcel Therapeutics, Inc. founded?
BioXcel Therapeutics, Inc. was founded in 2017.
Company Overview
- Headquarters
- 555 Long Wharf Dr 12th floor New Haven, Connecticut 06511 US
- Phone number
- +1-203-643-****
- Website
- bioxceltherapeutics.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- Stock Symbol
- BTAI
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2017
- Employees
- 51-200
Media & News
Funding & Financials
- $10M$50M
BioXcel Therapeutics, Inc.'s revenue is in the range of $10M$50M
Funding & Financials
- $10M$50M
BioXcel Therapeutics, Inc.'s revenue is in the range of $10M$50M
Company Leadership
V. M.Chief Executive Officer
R. R.Chief Medical Officer, Neuroscience- V. J.Chief Medical Officer
- W. K.Chief Commercial Officer
- M. D. V.Vice President Of Neuroscience
Employee Directory
- R. R.Chief Medical Officer, Neuroscience
- V. J.Chief Medical Officer
- W. K.Chief Commercial Officer
M. M.Vp, Clinical Development- J. K.Head Of Ai
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
